Multi Bintang Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Multi Bintang Indonesia Tbk. trades at Rp6,325 (market cap 13.33T, 51.1K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Multi Bintang Indonesia Tbk. is far larger — about 79.6× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (96.7K versus 51.1K). Which is the better fit depends on your goals.
| MLBI | OBAT | |
|---|---|---|
Market Cap | 13.33T | 167.37B |
Volume | 51.1K | 96.7K |
Lot | 511 | 967 |
Turnover | 322.91M | 23.82M |
Average Price | 6,319.08 | 246.34 |
Value | 322.91M | 23.82M |
Indicative Equilibrium Price | — | 248 |
Indicative Equilibrium Volume | — | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Multi Bintang Indonesia Tbk (The Company) was established on June 3, 1929, based on notarial deed No. 8 of Tjeerd Dijkstra, notary public in Medan, under the name of NV Nederlandsch Indische Bierbrouwerijen. The Company is part of the Heineken Group, where the ultimate shareholder is Heineken N.V. (Heineken).
Read more on MLBI →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →